Contralateral Breast Cancer Risk among Carriers of Germline Pathogenic Variants in ATM, BRCA1, BRCA2, CHEK2, and PALB2

  1. Yadav, S.
  2. Boddicker, N.J.
  3. Na, J.
  4. Polley, E.C.
  5. Hu, C.
  6. Hart, S.N.
  7. Gnanaolivu, R.D.
  8. Larson, N.
  9. Holtegaard, S.
  10. Huang, H.
  11. Dunn, C.A.
  12. Teras, L.R.
  13. Patel, A.V.
  14. Lacey, J.V.
  15. Neuhausen, S.L.
  16. Martinez, E.
  17. Haiman, C.
  18. Chen, F.
  19. Ruddy, K.J.
  20. Olson, J.E.
  21. John, E.M.
  22. Kurian, A.W.
  23. Sandler, D.P.
  24. O'Brien, K.M.
  25. Taylor, J.A.
  26. Weinberg, C.R.
  27. Anton-Culver, H.
  28. Ziogas, A.
  29. Zirpoli, G.
  30. Goldgar, D.E.
  31. Palmer, J.R.
  32. Domchek, S.M.
  33. Weitzel, J.N.
  34. Nathanson, K.L.
  35. Kraft, P.
  36. Couch, F.J.
  37. Show all authors +
Journal:
Journal of Clinical Oncology

ISSN: 1527-7755 0732-183X

Year of publication: 2023

Volume: 41

Issue: 9

Pages: 1703-1713

Type: Article

DOI: 10.1200/JCO.22.01239 GOOGLE SCHOLAR lock_openOpen access editor